nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.139	0.264	CbGbCtD
Raloxifene—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.105	0.2	CbGbCtD
Raloxifene—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0594	0.113	CbGbCtD
Raloxifene—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0458	0.0872	CbGbCtD
Raloxifene—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0442	0.0842	CbGbCtD
Raloxifene—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0426	0.0811	CbGbCtD
Raloxifene—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0398	0.0758	CbGbCtD
Raloxifene—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0196	0.0372	CbGbCtD
Raloxifene—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0179	0.0341	CbGbCtD
Raloxifene—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0122	0.0233	CbGbCtD
Raloxifene—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000632	0.00169	CcSEcCtD
Raloxifene—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.00063	0.00169	CcSEcCtD
Raloxifene—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.00063	0.00169	CcSEcCtD
Raloxifene—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000627	0.00168	CcSEcCtD
Raloxifene—Vaginal infection—Doxorubicin—peripheral nervous system neoplasm	0.000627	0.00168	CcSEcCtD
Raloxifene—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000626	0.00168	CcSEcCtD
Raloxifene—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000621	0.00167	CcSEcCtD
Raloxifene—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000618	0.00166	CcSEcCtD
Raloxifene—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000616	0.00165	CcSEcCtD
Raloxifene—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000616	0.00165	CcSEcCtD
Raloxifene—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000611	0.00164	CcSEcCtD
Raloxifene—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000611	0.00164	CcSEcCtD
Raloxifene—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000611	0.00164	CcSEcCtD
Raloxifene—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000611	0.00164	CcSEcCtD
Raloxifene—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000611	0.00164	CcSEcCtD
Raloxifene—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000611	0.00164	CcSEcCtD
Raloxifene—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000611	0.00164	CcSEcCtD
Raloxifene—Cramps of lower extremities—Doxorubicin—peripheral nervous system neoplasm	0.00061	0.00164	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000606	0.00163	CcSEcCtD
Raloxifene—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000602	0.00162	CcSEcCtD
Raloxifene—Bladder pain—Doxorubicin—peripheral nervous system neoplasm	0.000601	0.00161	CcSEcCtD
Raloxifene—Diabetes mellitus—Epirubicin—peripheral nervous system neoplasm	0.000599	0.00161	CcSEcCtD
Raloxifene—Flushing—Etoposide—peripheral nervous system neoplasm	0.000597	0.0016	CcSEcCtD
Raloxifene—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000597	0.0016	CcSEcCtD
Raloxifene—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000588	0.00158	CcSEcCtD
Raloxifene—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000588	0.00158	CcSEcCtD
Raloxifene—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000584	0.00157	CcSEcCtD
Raloxifene—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000582	0.00156	CcSEcCtD
Raloxifene—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000576	0.00154	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000575	0.00154	CcSEcCtD
Raloxifene—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000574	0.00154	CcSEcCtD
Raloxifene—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000573	0.00154	CcSEcCtD
Raloxifene—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000569	0.00152	CcSEcCtD
Raloxifene—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000566	0.00152	CcSEcCtD
Raloxifene—Infection—Vincristine—peripheral nervous system neoplasm	0.00056	0.0015	CcSEcCtD
Raloxifene—Hot flush—Epirubicin—peripheral nervous system neoplasm	0.000557	0.00149	CcSEcCtD
Raloxifene—Diabetes mellitus—Doxorubicin—peripheral nervous system neoplasm	0.000554	0.00149	CcSEcCtD
Raloxifene—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000553	0.00148	CcSEcCtD
Raloxifene—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	0.000552	0.00148	CcSEcCtD
Raloxifene—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000552	0.00148	CcSEcCtD
Raloxifene—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000545	0.00146	CcSEcCtD
Raloxifene—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00054	0.00145	CcSEcCtD
Raloxifene—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000538	0.00144	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000533	0.00143	CcSEcCtD
Raloxifene—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000533	0.00143	CcSEcCtD
Raloxifene—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	0.000532	0.00143	CcSEcCtD
Raloxifene—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000529	0.00142	CcSEcCtD
Raloxifene—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000528	0.00142	CcSEcCtD
Raloxifene—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000528	0.00142	CcSEcCtD
Raloxifene—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000522	0.0014	CcSEcCtD
Raloxifene—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.00052	0.0014	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000517	0.00139	CcSEcCtD
Raloxifene—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000516	0.00138	CcSEcCtD
Raloxifene—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000515	0.00138	CcSEcCtD
Raloxifene—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000515	0.00138	CcSEcCtD
Raloxifene—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000515	0.00138	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000514	0.00138	CcSEcCtD
Raloxifene—Migraine—Epirubicin—peripheral nervous system neoplasm	0.000513	0.00138	CcSEcCtD
Raloxifene—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000511	0.00137	CcSEcCtD
Raloxifene—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000511	0.00137	CcSEcCtD
Raloxifene—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000511	0.00137	CcSEcCtD
Raloxifene—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00051	0.00137	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000505	0.00136	CcSEcCtD
Raloxifene—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000503	0.00135	CcSEcCtD
Raloxifene—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000501	0.00134	CcSEcCtD
Raloxifene—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000499	0.00134	CcSEcCtD
Raloxifene—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000499	0.00134	CcSEcCtD
Raloxifene—Infection—Cisplatin—peripheral nervous system neoplasm	0.000496	0.00133	CcSEcCtD
Raloxifene—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000495	0.00133	CcSEcCtD
Raloxifene—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000492	0.00132	CcSEcCtD
Raloxifene—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000492	0.00132	CcSEcCtD
Raloxifene—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000491	0.00132	CcSEcCtD
Raloxifene—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000491	0.00132	CcSEcCtD
Raloxifene—Rash—Topotecan—peripheral nervous system neoplasm	0.000491	0.00132	CcSEcCtD
Raloxifene—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00049	0.00132	CcSEcCtD
Raloxifene—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000489	0.00131	CcSEcCtD
Raloxifene—Cough—Etoposide—peripheral nervous system neoplasm	0.000489	0.00131	CcSEcCtD
Raloxifene—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000488	0.00131	CcSEcCtD
Raloxifene—Headache—Topotecan—peripheral nervous system neoplasm	0.000488	0.00131	CcSEcCtD
Raloxifene—Rash—Tretinoin—peripheral nervous system neoplasm	0.000487	0.00131	CcSEcCtD
Raloxifene—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000487	0.00131	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000487	0.00131	CcSEcCtD
Raloxifene—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000487	0.0013	CcSEcCtD
Raloxifene—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000487	0.0013	CcSEcCtD
Raloxifene—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000485	0.0013	CcSEcCtD
Raloxifene—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000484	0.0013	CcSEcCtD
Raloxifene—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000484	0.0013	CcSEcCtD
Raloxifene—Headache—Tretinoin—peripheral nervous system neoplasm	0.000484	0.0013	CcSEcCtD
Raloxifene—Pain—Vincristine—peripheral nervous system neoplasm	0.000482	0.00129	CcSEcCtD
Raloxifene—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000482	0.00129	CcSEcCtD
Raloxifene—Rash—Melphalan—peripheral nervous system neoplasm	0.000481	0.00129	CcSEcCtD
Raloxifene—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00048	0.00129	CcSEcCtD
Raloxifene—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000479	0.00128	CcSEcCtD
Raloxifene—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000477	0.00128	CcSEcCtD
Raloxifene—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000475	0.00127	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000473	0.00127	CcSEcCtD
Raloxifene—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000471	0.00126	CcSEcCtD
Raloxifene—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000469	0.00126	CcSEcCtD
Raloxifene—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000463	0.00124	CcSEcCtD
Raloxifene—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000463	0.00124	CcSEcCtD
Raloxifene—Nausea—Topotecan—peripheral nervous system neoplasm	0.000462	0.00124	CcSEcCtD
Raloxifene—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000461	0.00124	CcSEcCtD
Raloxifene—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000459	0.00123	CcSEcCtD
Raloxifene—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000459	0.00123	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000454	0.00122	CcSEcCtD
Raloxifene—Infection—Etoposide—peripheral nervous system neoplasm	0.000454	0.00122	CcSEcCtD
Raloxifene—Nausea—Melphalan—peripheral nervous system neoplasm	0.000453	0.00121	CcSEcCtD
Raloxifene—Influenza—Epirubicin—peripheral nervous system neoplasm	0.00045	0.00121	CcSEcCtD
Raloxifene—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000447	0.0012	CcSEcCtD
Raloxifene—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000446	0.0012	CcSEcCtD
Raloxifene—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000446	0.0012	CcSEcCtD
Raloxifene—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000444	0.00119	CcSEcCtD
Raloxifene—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000442	0.00118	CcSEcCtD
Raloxifene—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000436	0.00117	CcSEcCtD
Raloxifene—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000434	0.00116	CcSEcCtD
Raloxifene—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000433	0.00116	CcSEcCtD
Raloxifene—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000432	0.00116	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000431	0.00115	CcSEcCtD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000427	0.0042	CbGpPWpGaD
Raloxifene—Pain—Cisplatin—peripheral nervous system neoplasm	0.000427	0.00114	CcSEcCtD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.00042	0.00413	CbGpPWpGaD
Raloxifene—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000417	0.00112	CcSEcCtD
Raloxifene—ESR1—FOXM1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000416	0.00409	CbGpPWpGaD
Raloxifene—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.00041	0.0011	CcSEcCtD
Raloxifene—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000404	0.00108	CcSEcCtD
Raloxifene—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000401	0.00108	CcSEcCtD
Raloxifene—HTR6—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.000401	0.00394	CbGpPWpGaD
Raloxifene—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.00107	CcSEcCtD
Raloxifene—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000401	0.00107	CcSEcCtD
Raloxifene—ESR2—Validated nuclear estrogen receptor alpha network—MYC—peripheral nervous system neoplasm	0.0004	0.00392	CbGpPWpGaD
Raloxifene—EBP—Metabolism—GNS—peripheral nervous system neoplasm	0.000398	0.00391	CbGpPWpGaD
Raloxifene—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000398	0.00107	CcSEcCtD
Raloxifene—ESR2—Plasma membrane estrogen receptor signaling—AKT1—peripheral nervous system neoplasm	0.000396	0.00389	CbGpPWpGaD
Raloxifene—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000394	0.00106	CcSEcCtD
Raloxifene—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000394	0.00106	CcSEcCtD
Raloxifene—Pain—Etoposide—peripheral nervous system neoplasm	0.000391	0.00105	CcSEcCtD
Raloxifene—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.00039	0.00105	CcSEcCtD
Raloxifene—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.00039	0.00105	CcSEcCtD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.000389	0.00382	CbGpPWpGaD
Raloxifene—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000387	0.00104	CcSEcCtD
Raloxifene—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000386	0.00104	CcSEcCtD
Raloxifene—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000385	0.00103	CcSEcCtD
Raloxifene—EBP—Metabolism—NME1—peripheral nervous system neoplasm	0.000382	0.00375	CbGpPWpGaD
Raloxifene—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000379	0.00102	CcSEcCtD
Raloxifene—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000377	0.00101	CcSEcCtD
Raloxifene—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000375	0.00101	CcSEcCtD
Raloxifene—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000374	0.001	CcSEcCtD
Raloxifene—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000374	0.001	CcSEcCtD
Raloxifene—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000373	0.001	CcSEcCtD
Raloxifene—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000372	0.000998	CcSEcCtD
Raloxifene—HTR6—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000371	0.00364	CbGpPWpGaD
Raloxifene—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000369	0.00099	CcSEcCtD
Raloxifene—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000369	0.000989	CcSEcCtD
Raloxifene—EBP—Metabolism—COX2—peripheral nervous system neoplasm	0.000367	0.00361	CbGpPWpGaD
Raloxifene—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000367	0.000984	CcSEcCtD
Raloxifene—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000969	CcSEcCtD
Raloxifene—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000361	0.000969	CcSEcCtD
Raloxifene—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000361	0.000969	CcSEcCtD
Raloxifene—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000969	CcSEcCtD
Raloxifene—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000969	CcSEcCtD
Raloxifene—ESR2—Gene Expression—EED—peripheral nervous system neoplasm	0.00036	0.00354	CbGpPWpGaD
Raloxifene—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000962	CcSEcCtD
Raloxifene—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000359	0.000962	CcSEcCtD
Raloxifene—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000358	0.00096	CcSEcCtD
Raloxifene—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.000955	CcSEcCtD
Raloxifene—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000356	0.000955	CcSEcCtD
Raloxifene—Rash—Vincristine—peripheral nervous system neoplasm	0.000356	0.000954	CcSEcCtD
Raloxifene—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000355	0.000953	CcSEcCtD
Raloxifene—HTR6—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000355	0.00349	CbGpPWpGaD
Raloxifene—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000355	0.000953	CcSEcCtD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000354	0.00348	CbGpPWpGaD
Raloxifene—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000354	0.00095	CcSEcCtD
Raloxifene—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000353	0.000948	CcSEcCtD
Raloxifene—Headache—Vincristine—peripheral nervous system neoplasm	0.000353	0.000948	CcSEcCtD
Raloxifene—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000935	CcSEcCtD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.000348	0.00342	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000348	0.00342	CbGpPWpGaD
Raloxifene—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000348	0.000933	CcSEcCtD
Raloxifene—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000341	0.000915	CcSEcCtD
Raloxifene—HTR2B—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000338	0.00332	CbGpPWpGaD
Raloxifene—Nausea—Vincristine—peripheral nervous system neoplasm	0.000335	0.000899	CcSEcCtD
Raloxifene—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000897	CcSEcCtD
Raloxifene—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000897	CcSEcCtD
Raloxifene—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000897	CcSEcCtD
Raloxifene—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.00089	CcSEcCtD
Raloxifene—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000888	CcSEcCtD
Raloxifene—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.000884	CcSEcCtD
Raloxifene—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.000881	CcSEcCtD
Raloxifene—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.000879	CcSEcCtD
Raloxifene—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000327	0.000877	CcSEcCtD
Raloxifene—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000327	0.000877	CcSEcCtD
Raloxifene—HTR2B—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000324	0.00319	CbGpPWpGaD
Raloxifene—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000317	0.000851	CcSEcCtD
Raloxifene—ESR1—Leptin signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000317	0.00311	CbGpPWpGaD
Raloxifene—ESR1—Estrogen signaling pathway—AKT1—peripheral nervous system neoplasm	0.000317	0.00311	CbGpPWpGaD
Raloxifene—Rash—Cisplatin—peripheral nervous system neoplasm	0.000314	0.000843	CcSEcCtD
Raloxifene—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000314	0.000843	CcSEcCtD
Raloxifene—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000313	0.000838	CcSEcCtD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000311	0.00306	CbGpPWpGaD
Raloxifene—CYP19A1—FSH signaling pathway—AKT1—peripheral nervous system neoplasm	0.000311	0.00306	CbGpPWpGaD
Raloxifene—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.00083	CcSEcCtD
Raloxifene—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.00083	CcSEcCtD
Raloxifene—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000829	CcSEcCtD
Raloxifene—ESR1—Plasma membrane estrogen receptor signaling—NRAS—peripheral nervous system neoplasm	0.000309	0.00303	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000305	0.003	CbGpPWpGaD
Raloxifene—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000812	CcSEcCtD
Raloxifene—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000302	0.00081	CcSEcCtD
Raloxifene—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000809	CcSEcCtD
Raloxifene—HTR2B—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.000301	0.00296	CbGpPWpGaD
Raloxifene—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000296	0.000795	CcSEcCtD
Raloxifene—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000291	0.000779	CcSEcCtD
Raloxifene—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000288	0.00283	CbGpPWpGaD
Raloxifene—Rash—Etoposide—peripheral nervous system neoplasm	0.000288	0.000773	CcSEcCtD
Raloxifene—ESR2—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000288	0.00283	CbGpPWpGaD
Raloxifene—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000288	0.000772	CcSEcCtD
Raloxifene—Headache—Etoposide—peripheral nervous system neoplasm	0.000286	0.000768	CcSEcCtD
Raloxifene—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000767	CcSEcCtD
Raloxifene—ESR1—FOXM1 transcription factor network—MYC—peripheral nervous system neoplasm	0.000282	0.00277	CbGpPWpGaD
Raloxifene—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000756	CcSEcCtD
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.000282	0.00277	CbGpPWpGaD
Raloxifene—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000755	CcSEcCtD
Raloxifene—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000749	CcSEcCtD
Raloxifene—ESR1—LKB1 signaling events—MYC—peripheral nervous system neoplasm	0.000277	0.00272	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000277	0.00272	CbGpPWpGaD
Raloxifene—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000276	0.00074	CcSEcCtD
Raloxifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000275	0.0027	CbGpPWpGaD
Raloxifene—Cough—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000734	CcSEcCtD
Raloxifene—Nausea—Etoposide—peripheral nervous system neoplasm	0.000271	0.000728	CcSEcCtD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.00027	0.00265	CbGpPWpGaD
Raloxifene—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	0.000268	0.00263	CbGpPWpGaD
Raloxifene—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000717	CcSEcCtD
Raloxifene—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000717	CcSEcCtD
Raloxifene—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000717	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000712	CcSEcCtD
Raloxifene—AOX1—Disease—GNS—peripheral nervous system neoplasm	0.000263	0.00259	CbGpPWpGaD
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.000262	0.00258	CbGpPWpGaD
Raloxifene—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.0007	CcSEcCtD
Raloxifene—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000698	CcSEcCtD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000258	0.00253	CbGpPWpGaD
Raloxifene—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000685	CcSEcCtD
Raloxifene—Infection—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000682	CcSEcCtD
Raloxifene—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.00068	CcSEcCtD
Raloxifene—Shock—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000676	CcSEcCtD
Raloxifene—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000674	CcSEcCtD
Raloxifene—ESR2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000251	0.00246	CbGpPWpGaD
Raloxifene—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000673	CcSEcCtD
Raloxifene—ESR1—Leptin signaling pathway—ERBB2—peripheral nervous system neoplasm	0.00025	0.00246	CbGpPWpGaD
Raloxifene—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000667	CcSEcCtD
Raloxifene—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000664	CcSEcCtD
Raloxifene—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000663	CcSEcCtD
Raloxifene—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000663	CcSEcCtD
Raloxifene—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000663	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000658	CcSEcCtD
Raloxifene—EBP—Metabolism—ENO2—peripheral nervous system neoplasm	0.000241	0.00237	CbGpPWpGaD
Raloxifene—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000631	CcSEcCtD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000235	0.00231	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000235	0.00231	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000234	0.0023	CbGpPWpGaD
Raloxifene—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000626	CcSEcCtD
Raloxifene—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000625	CcSEcCtD
Raloxifene—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000623	CcSEcCtD
Raloxifene—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000622	CcSEcCtD
Raloxifene—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000621	CcSEcCtD
Raloxifene—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000617	CcSEcCtD
Raloxifene—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000614	CcSEcCtD
Raloxifene—ESR1—LKB1 signaling events—TP53—peripheral nervous system neoplasm	0.000227	0.00223	CbGpPWpGaD
Raloxifene—ESR1—Plasma membrane estrogen receptor signaling—HRAS—peripheral nervous system neoplasm	0.000226	0.00222	CbGpPWpGaD
Raloxifene—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000605	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000593	CcSEcCtD
Raloxifene—AOX1—Metabolism—GNS—peripheral nervous system neoplasm	0.000221	0.00217	CbGpPWpGaD
Raloxifene—Pain—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000587	CcSEcCtD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000219	0.00215	CbGpPWpGaD
Raloxifene—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000579	CcSEcCtD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000215	0.00212	CbGpPWpGaD
Raloxifene—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000575	CcSEcCtD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000213	0.0021	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000212	0.00208	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—NME1—peripheral nervous system neoplasm	0.000212	0.00208	CbGpPWpGaD
Raloxifene—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000562	CcSEcCtD
Raloxifene—HTR6—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000209	0.00206	CbGpPWpGaD
Raloxifene—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.00056	CcSEcCtD
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	0.000206	0.00202	CbGpPWpGaD
Raloxifene—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000549	CcSEcCtD
Raloxifene—EBP—Metabolism—BCHE—peripheral nervous system neoplasm	0.000204	0.002	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—COX2—peripheral nervous system neoplasm	0.000204	0.002	CbGpPWpGaD
Raloxifene—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000544	CcSEcCtD
Raloxifene—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000543	CcSEcCtD
Raloxifene—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000543	CcSEcCtD
Raloxifene—ESR1—Validated nuclear estrogen receptor alpha network—MYC—peripheral nervous system neoplasm	0.000201	0.00198	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.0002	0.00196	CbGpPWpGaD
Raloxifene—ESR1—Plasma membrane estrogen receptor signaling—AKT1—peripheral nervous system neoplasm	0.000199	0.00196	CbGpPWpGaD
Raloxifene—EBP—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000194	0.00191	CbGpPWpGaD
Raloxifene—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.00052	CcSEcCtD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000193	0.00189	CbGpPWpGaD
Raloxifene—ESR1—Regulation of Telomerase—MYC—peripheral nervous system neoplasm	0.000192	0.00189	CbGpPWpGaD
Raloxifene—EBP—Metabolism—TH—peripheral nervous system neoplasm	0.000192	0.00188	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000191	0.00188	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00019	0.00187	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	0.000188	0.00184	CbGpPWpGaD
Raloxifene—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000502	CcSEcCtD
Raloxifene—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000502	CcSEcCtD
Raloxifene—AOX1—Disease—PPP3R1—peripheral nervous system neoplasm	0.000184	0.00181	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000182	0.00179	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—EED—peripheral nervous system neoplasm	0.000182	0.00179	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	0.00018	0.00177	CbGpPWpGaD
Raloxifene—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000175	0.00047	CcSEcCtD
Raloxifene—HTR2B—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000174	0.00171	CbGpPWpGaD
Raloxifene—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000454	CcSEcCtD
Raloxifene—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	0.000167	0.00164	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000167	0.00164	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000166	0.00164	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000166	0.00163	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000164	0.00161	CbGpPWpGaD
Raloxifene—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000437	CcSEcCtD
Raloxifene—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000435	CcSEcCtD
Raloxifene—Rash—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000433	CcSEcCtD
Raloxifene—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000433	CcSEcCtD
Raloxifene—Headache—Epirubicin—peripheral nervous system neoplasm	0.00016	0.00043	CcSEcCtD
Raloxifene—AOX1—Disease—ENO2—peripheral nervous system neoplasm	0.00016	0.00157	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000159	0.00156	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000158	0.00155	CbGpPWpGaD
Raloxifene—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.00042	CcSEcCtD
Raloxifene—EBP—Metabolism—GNAS—peripheral nervous system neoplasm	0.000156	0.00154	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	0.000154	0.00151	CbGpPWpGaD
Raloxifene—EBP—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000154	0.00151	CbGpPWpGaD
Raloxifene—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000408	CcSEcCtD
Raloxifene—HTR2B—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000152	0.00149	CbGpPWpGaD
Raloxifene—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000404	CcSEcCtD
Raloxifene—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00015	0.00147	CbGpPWpGaD
Raloxifene—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000401	CcSEcCtD
Raloxifene—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.0004	CcSEcCtD
Raloxifene—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000398	CcSEcCtD
Raloxifene—HTR6—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000146	0.00143	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000145	0.00143	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000145	0.00142	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000145	0.00142	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000144	0.00142	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—ERBB2—peripheral nervous system neoplasm	0.000142	0.0014	CbGpPWpGaD
Raloxifene—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000378	CcSEcCtD
Raloxifene—ESR1—Leptin signaling pathway—HRAS—peripheral nervous system neoplasm	0.000139	0.00137	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000137	0.00134	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000134	0.00131	CbGpPWpGaD
Raloxifene—ESR1—Regulation of Telomerase—AKT1—peripheral nervous system neoplasm	0.000133	0.00131	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000133	0.00131	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000133	0.00131	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000132	0.00129	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000131	0.00129	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.00013	0.00128	CbGpPWpGaD
Raloxifene—AOX1—Disease—SLC2A1—peripheral nervous system neoplasm	0.000129	0.00126	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000127	0.00125	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—AKT1—peripheral nervous system neoplasm	0.000123	0.00121	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000121	0.00119	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000119	0.00116	CbGpPWpGaD
Raloxifene—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	0.000116	0.00114	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000116	0.00113	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GNS—peripheral nervous system neoplasm	0.000114	0.00112	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000113	0.00111	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000113	0.00111	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000112	0.0011	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—NME1—peripheral nervous system neoplasm	0.000109	0.00107	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—NRAS—peripheral nervous system neoplasm	0.000108	0.00106	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000108	0.00106	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000108	0.00106	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000108	0.00106	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—TH—peripheral nervous system neoplasm	0.000106	0.00104	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—COX2—peripheral nervous system neoplasm	0.000105	0.00103	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000103	0.00101	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000101	0.000996	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000101	0.000996	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	9.85e-05	0.000967	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CD55—peripheral nervous system neoplasm	9.83e-05	0.000966	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	9.41e-05	0.000924	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	9.3e-05	0.000914	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GNAS—peripheral nervous system neoplasm	8.67e-05	0.000852	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	8.59e-05	0.000844	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.58e-05	0.000843	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	8.54e-05	0.000839	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	8.54e-05	0.000839	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—VIP—peripheral nervous system neoplasm	8.51e-05	0.000836	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—ABCB1—peripheral nervous system neoplasm	8.51e-05	0.000836	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	8.4e-05	0.000825	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	8.33e-05	0.000818	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	8.28e-05	0.000813	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	8.23e-05	0.000808	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	8.19e-05	0.000804	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	7.92e-05	0.000778	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.86e-05	0.000772	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	7.85e-05	0.000771	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.8e-05	0.000766	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.77e-05	0.000763	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	7.51e-05	0.000738	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	7.47e-05	0.000734	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	7.33e-05	0.00072	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	7.2e-05	0.000708	CbGpPWpGaD
Raloxifene—AOX1—Disease—PTPN11—peripheral nervous system neoplasm	7.19e-05	0.000707	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.17e-05	0.000705	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.13e-05	0.000701	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	7.03e-05	0.000691	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	7.02e-05	0.00069	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	6.99e-05	0.000687	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ENO2—peripheral nervous system neoplasm	6.91e-05	0.000679	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	6.9e-05	0.000678	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.82e-05	0.00067	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.82e-05	0.00067	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	6.76e-05	0.000664	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.47e-05	0.000636	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	6.2e-05	0.000609	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.97e-05	0.000587	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	5.95e-05	0.000584	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.9e-05	0.00058	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—BCHE—peripheral nervous system neoplasm	5.84e-05	0.000574	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.83e-05	0.000572	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	5.72e-05	0.000562	CbGpPWpGaD
Raloxifene—AOX1—Disease—ERBB2—peripheral nervous system neoplasm	5.69e-05	0.000559	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.57e-05	0.000547	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—TH—peripheral nervous system neoplasm	5.49e-05	0.00054	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.39e-05	0.000529	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	5.19e-05	0.00051	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.05e-05	0.000496	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.81e-05	0.000473	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.74e-05	0.000466	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.61e-05	0.000453	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.61e-05	0.000452	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.49e-05	0.000441	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GNAS—peripheral nervous system neoplasm	4.48e-05	0.00044	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	4.44e-05	0.000436	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.41e-05	0.000434	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ABCB1—peripheral nervous system neoplasm	4.4e-05	0.000432	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.39e-05	0.000431	CbGpPWpGaD
Raloxifene—AOX1—Disease—NRAS—peripheral nervous system neoplasm	4.33e-05	0.000425	CbGpPWpGaD
Raloxifene—EBP—Metabolism—AKT1—peripheral nervous system neoplasm	4.22e-05	0.000415	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	4.17e-05	0.00041	CbGpPWpGaD
Raloxifene—AOX1—Disease—MYC—peripheral nervous system neoplasm	4.03e-05	0.000396	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.03e-05	0.000396	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—MYC—peripheral nervous system neoplasm	3.98e-05	0.000391	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.84e-05	0.000377	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	3.76e-05	0.000369	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	3.75e-05	0.000369	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.66e-05	0.000359	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.58e-05	0.000352	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	3.53e-05	0.000346	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.36e-05	0.00033	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	3.33e-05	0.000327	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	3.19e-05	0.000314	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	3.18e-05	0.000312	CbGpPWpGaD
Raloxifene—AOX1—Disease—HRAS—peripheral nervous system neoplasm	3.16e-05	0.000311	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.12e-05	0.000307	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	3.07e-05	0.000302	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.07e-05	0.000301	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.03e-05	0.000298	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	2.99e-05	0.000293	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	2.88e-05	0.000283	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.85e-05	0.00028	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	2.83e-05	0.000278	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.8e-05	0.000275	CbGpPWpGaD
Raloxifene—AOX1—Disease—AKT1—peripheral nervous system neoplasm	2.79e-05	0.000274	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—AKT1—peripheral nervous system neoplasm	2.76e-05	0.000271	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	2.44e-05	0.000239	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.42e-05	0.000238	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	2.39e-05	0.000235	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—AKT1—peripheral nervous system neoplasm	2.34e-05	0.00023	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.33e-05	0.000229	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.28e-05	0.000224	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.22e-05	0.000218	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.21e-05	0.000217	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.2e-05	0.000216	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.08e-05	0.000205	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.03e-05	0.000199	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	2.02e-05	0.000198	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.02e-05	0.000198	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—MYC—peripheral nervous system neoplasm	2.01e-05	0.000197	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.01e-05	0.000197	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.84e-05	0.000181	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.84e-05	0.000181	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.84e-05	0.000181	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.72e-05	0.000169	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.7e-05	0.000167	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.68e-05	0.000165	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.67e-05	0.000164	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.63e-05	0.00016	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.6e-05	0.000157	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.57e-05	0.000154	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.41e-05	0.000139	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.4e-05	0.000138	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—AKT1—peripheral nervous system neoplasm	1.39e-05	0.000137	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.35e-05	0.000133	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.31e-05	0.000129	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.31e-05	0.000128	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.29e-05	0.000127	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.28e-05	0.000126	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.23e-05	0.000121	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.21e-05	0.000119	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.19e-05	0.000117	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.09e-05	0.000107	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.07e-05	0.000105	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.03e-05	0.000101	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.06e-06	8.9e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	7.77e-06	7.63e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	6.58e-06	6.46e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	3.53e-06	3.47e-05	CbGpPWpGaD
